The pharma play has been derisked with negligible impact from tariff announcements. Healthcare and diagnostics continue to be supported by rising insurance penetration and demand for private ...

Creating custom outfits in "Roblox" has become one of the most popular ways for young creators to express themselves and even earn Robux. Whether you enjoy fashion, want to design your own style, or ...

Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...

Nov 7 (Reuters) - Indian drugmaker Divi's Laboratories (DIVI.NS), opens new tab reported second-quarter profit above analysts' estimates on Friday, helped by its business that focuses on customised ...

(Reuters) -Indian drugmaker Divi’s Laboratories reported second-quarter profit above analysts’ estimates on Friday, helped by its business that focuses on customised production of chemical compounds ...

Boating in real life? Hard pass. I’m not exactly Sir Ben Ainslie in sailing. But a virtual sail? I’ll happily jump aboard. Roblox Make a Boat takes that thrill one step further by letting you build ...

Thinking Machines, the AI startup founded earlier this year by former OpenAI CTO Mira Murati, has launched its first product: Tinker, a Python-based API designed to make large language model (LLM) ...

ALEXANDRIA, Va., Sept. 30, 2025 /PRNewswire/ -- Luxand ?loud, a provider of facial recognition, detection, and analysis APIs, announced the release of its Baby Maker API and Aging API. These ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Roblox now has more than 750,000 ...

According to ElevenLabs (@elevenlabsio), the company has launched Jingle Maker, an innovative tool that utilizes the Eleven Music API to generate custom songs based on a user's X profile or website in ...

The combination of Padcev and Keytruda delivered a phase 3 win in muscle-invasive bladder cancer. China did not renew the conditional approval for a controversial Alzheimer's disease drug. Fosun ...